Nimotuzumab Combined With TGP as First-line Therapy in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma
Clinical trial NCT06509009 · RECRUITING
Trial details
- NCT number
- NCT06509009
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-30
- Primary completion
- 2026-05-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.